Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2024-04-23 00:00:00 ET · period of report 2024-04-22 · accession 0000950170-24-046871 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-23 | 2024-04-22 | KPTI | Rangwala Reshma | EVP, Chief Medical Off | S - Sale | $1.17 | -6,789 | 342.9K | -2% | -$7,943 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-22 | S | D | 6,789 | $1.17 | 342,931 | D | — | — |